October 12, 2022
We are excited to announce the grand opening (October 12, 2022) of our new Naperville, Chicago location!
Our new facility is only 30 minutes from the Chicago O’Hare airport and encompasses over 3,000m2 (29,283 sq ft) of innovative scientific equipment and highly trained staff.
Join us for a tour and see how CellCarta is dedicated to advancing scientific research.
At Naperville, we offer leading testing services for all phases of clinical trials including:
Our Naperville facility is designed to provide comprehensive testing services across various phases of clinical trials. Our advanced genomic capabilities include-
These techniques are essential for precise genetic analysis and biomarker discovery, aiding in the development of targeted therapies and personalized medicine.
In addition to our robust genomic services, we offer state-of-the-art histopathology services.
As a CAP/CLIA certified lab, we support clinical studies for diagnostic and pharmaceutical partners in preparation for FDA, EU and other global submissions.
As a CAP/CLIA certified laboratory, we adhere to the highest standards of quality and compliance. Our rigorous quality control measures ensure the reliability and accuracy of our data, supporting clinical studies for regulatory submissions worldwide, including FDA and EU approvals.
Located just 30 minutes from Chicago O’Hare airport, our Naperville facility is easily accessible for local and international clients. The facility spans over 3,000m² (29,283 sq ft) and is equipped with the latest scientific equipment, operated by a team of highly trained professionals dedicated to advancing scientific research.
CellCarta is committed to delivering high-quality, reliable data through our extensive range of testing services and advanced technologies. Our new Naperville facility exemplifies our dedication to supporting clinical trials and research initiatives with state-of-the-art resources and expert staff.